Fibrocell Science Inc buy melinda
Start price
09.09.17
/
50%
€2.90
Target price
19.12.17
€3.97
Performance (%)
-78.57%
End price
19.12.17
€0.62
Summary
This prediction ended on 19.12.17 with a price of €0.62. Massive losses of -78.57% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fibrocell Science Inc | - | - | - | - |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % | 61,27 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % | 90,63 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % | 67,98 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % | 62,52 % |
Comments by melinda for this prediction
In the thread Fibrocell Science Inc diskutieren
zu folgen
Phase 1/2 Einleitung der Therapie am 23. Februar angekündigt, 2017. Phase 1 Daten für 3Q 2017
(Vom Mitglied beendet)
Stopped prediction by melinda for Fibrocell Science Inc
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.22
09.09.17
09.09.17
€4.40
19.12.17
19.12.17
-78.57%
19.12.17
19.12.17
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.08
26.06.17
26.06.17
€3.43
27.06.17
27.06.17
11.70%
27.06.17
27.06.17